Hou M C, Lin H C, Kuo B I, Liao T M, Lee F Y, Chang F Y, Lee S D
Department of Medicine, Veterans General Hospital-Taipei and National Yang-Ming University School of Medicine, Taiwan, Republic of China.
J Hepatol. 1998 Nov;29(5):772-8. doi: 10.1016/s0168-8278(98)80258-4.
BACKGROUND/AIMS: The risk factors for esophageal variceal rebleeding are little known. Variceal pressure is one of the major determinants of variceal rupture, but the relationship between variceal pressure and variceal rebleeding during maintenance sclerotherapy has not been determined. This study was undertaken to evaluate the relationship between variceal pressure/gradient change and variceal rebleeding during maintenance sclerotherapy.
Patients with liver cirrhosis and recent esophageal variceal hemorrhage underwent consecutive variceal pressure measurements by direct puncture of the varices before each elective sclerotherapy.
In 46 patients, the initial variceal pressure was no different regardless of age, sex, underlying etiology or hepatic reserve. Variceal pressure was higher in large varices, varices with more severe red wale markings, and varices with slower reduction in size during maintenance sclerotherapy. A larger volume of sclerosant was required to eradicate large varices, varices with more severe red wale markings, and varices with slower reduction in size during maintenance sclerotherapy. There was a positive correlation between initial variceal pressure and total amount of sclerosant (r=0.485, p=0.001). Initial variceal pressure was not related to rebleeding. Variceal pressure increased more in patients with rebleeding from varices per se (n=7) than in those without rebleeding (n= 24). There was no difference in pressure change between patients without rebleeding (n=24) and those with rebleeding from variceal ulcers (n=7).
Large varices, severe red color signs and slow reduction in variceal size were associated with higher initial variceal pressure, and more sclerosant was required to eradicate the varices. An increase in variceal pressure during maintenance sclerotherapy indicates a higher risk of variceal rebleeding, but not of variceal ulcer rebleeding.
背景/目的:食管静脉曲张再出血的危险因素鲜为人知。曲张静脉压力是曲张静脉破裂的主要决定因素之一,但维持硬化治疗期间曲张静脉压力与曲张静脉再出血之间的关系尚未明确。本研究旨在评估维持硬化治疗期间曲张静脉压力/梯度变化与曲张静脉再出血之间的关系。
肝硬化并近期发生食管静脉曲张出血的患者在每次择期硬化治疗前通过直接穿刺曲张静脉进行连续的曲张静脉压力测量。
46例患者中,无论年龄、性别、潜在病因或肝脏储备情况如何,初始曲张静脉压力均无差异。在大的曲张静脉、有更严重红色条纹的曲张静脉以及维持硬化治疗期间尺寸缩小较慢的曲张静脉中,曲张静脉压力更高。根除大的曲张静脉、有更严重红色条纹的曲张静脉以及维持硬化治疗期间尺寸缩小较慢的曲张静脉需要更大剂量的硬化剂。初始曲张静脉压力与硬化剂总量之间存在正相关(r = 0.485,p = 0.001)。初始曲张静脉压力与再出血无关。本身曲张静脉出血的患者(n = 7)曲张静脉压力升高幅度大于未出血患者(n = 24)。未出血患者(n = 24)与曲张静脉溃疡出血患者(n = 7)之间的压力变化无差异。
大的曲张静脉、严重的红色体征以及曲张静脉尺寸缩小缓慢与较高的初始曲张静脉压力相关,根除这些曲张静脉需要更多的硬化剂。维持硬化治疗期间曲张静脉压力升高表明曲张静脉再出血风险较高,但曲张静脉溃疡再出血风险并非如此。